Team Philippe RONDARD

Neuroreceptors, dynamics and functions

Philippe Rondard
DR1, Inserm

The team has an extensive experience in neuropharmacology and the study of G protein-coupled receptors (GPCRs), which are the target of over 30% of all drugs. Our team has made important discoveries in the molecular pharmacology of two types of receptors, the glutamate receptor (mGlu) and the GABA-B receptor, which are the targets of two major neurotransmitters, glutamate and GABA respectively. The study of their molecular mechanisms using innovative biophysical and biochemical techniques has led to the discovery of novel allosteric modulators with important applications for neurological and psychiatric diseases.